Surfactant therapy and spontaneous diuresis.
The effect of artificial surfactant therapy on renal function and the onset of spontaneous diuresis was prospectively evaluated in 19 infants with hyaline membrane disease in a double-blind, controlled study. Twelve infants were in the surfactant group; seven infants received placebo (0.9% saline solution). There was no difference in the time of onset of spontaneous diuresis (as defined by output greater than or equal to 80% of intake). The glomerular filtration rate, determined by endogenous creatinine clearance, was also similar in the surfactant- and placebo-treated infants during the first 3 days of life. The fractional excretion of sodium was significantly higher in the placebo group at 24 hours and 36 hours. Infants in the placebo group had a higher negative sodium balance than those in the surfactant group. Ventilatory status improved significantly soon after surfactant treatment, as evidenced by improvement in the alveolar/arterial oxygen pressure ratio and by a lower mean airway pressure. These data suggest that ventilatory status can be improved without diuresis; the factors that regulate diuresis are multiple and not fully understood.
Bhat
R
R
Department of Pediatrics, University of Illinois, Chicago.
John
E
E
Diaz-Blanco
J
J
Ortega
R
R
Fornell
L
L
Vidyasagar
D
D
D001784:Blood Gas Analysis; D001835:Body Weight; D002986:Clinical Trials as Topic; D004231:Diuresis; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006819:Hyaline Membrane Disease / Q000188:drug therapy*; D007230:Infant, Low Birth Weight / Q000502:physiology*; D007231:Infant, Newborn; D007668:Kidney / Q000502:physiology*; D008168:Lung / Q000502:physiology*; D008297:Male; D010919:Placebos; D011446:Prospective Studies; D011663:Pulmonary Surfactants / Q000627:therapeutic use*; D011897:Random Allocation
D010919:Placebos; D011663:Pulmonary Surfactants